About 50% of human embryos derived via IVF (in vitro fertilization) are known to carry chromosomally abnormalities.
Even up to 40% of morphologically normal embryos harbor aneuploidies *. PGT-A (PGS) can improve pregnancy rates (70% pregnancy rate with PGT-A (PGS) vs 40% without PGT-A (PGS)) PGT-A (PGS) reduces incidence of early miscarriages and thus the number of IVF cycles the patient must undergo.